Home / Resources / Pharma R&D Annual Review 2023 Supplement: New Active Substances Launched During 2022

Pharma R&D Annual Review 2023 Supplement: New Active Substances Launched During 2022

Whitepaper
Clinical
NAS image_image-hero
The Pharma R&D Annual Review 2023 Supplement looks at new active substances (NASs), drugs launched onto the market for the first time, during 2022
Darkened Qualified calendar. Please allow all cookies to use functionality.

To enable the booking feature, please enable all cookies in your browser.